Suzhou Lixin Pharmaceutical co., Ltd, located in suzhou new district of China since 2000, is specialized in active pharmaceutical ingredients (APIs)and High-added-value intermediates. In pursuit of standard API market in and out of China since its establishment, lixin has built GMP certification workshops, Chemical Synthesis Workshops, facilities, and established standard quality management system and advanced quality control profile.

Oriented to international market of APIs and intermediate materials, Lixin has built strength cooperation with domestic and international pharmaceutical companies. With the innovation of production process and patent protection, it already has serious of APIs including antineoplastic medicine, cardiovascular medicine and so on.銆?n order to obtain favorable comments from customers on our high-quality products and standard quality management system, Lixin insist studying the process and product quality under the guidelines of ICH and the rules of SFDA.

Lixin has owned a group of chemical scientists and managers engaged in the pharmaceutical industry for decades of years. They strive to make innovations in new products research, development, technological reform, quality control, quality management, product sales and service, etc.

Suzhou Lixin Pharmaceutical Co.,Ltd aims to provide high-quality products and services with science and technology innovation to customers.